Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Receives the Prestigious Prix Galien for its Focal One® HIFU device
LYON, France , Dec. 08, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the award of the prestigious 2016 Prix Galien, in the Medical Device category, for its Focal One HIFU device dedicated to the treatment of localized prostate
View HTML
Toggle Summary EDAP Achieves 79% Growth in HIFU Revenue for First Nine Months of 2016
Highlights at the end of September 30, 2016 : Total cumulated revenue in 2016  up 22% year-over-year; Driven by HIFU growth, Gross Margin increases to 45%; 111% growth in HIFU revenues in Q3 of 2016 compared to Q3 2015; Company continues to show operating profit in 2016 at the end of Q3; Strong
View HTML
Toggle Summary EDAP to Report Third Quarter 2016 Financial Results on November 17, 2016
Conference Call and Webcast Scheduled for 8:30 a.m. ET
View HTML
Toggle Summary EDAP‘s Ablatherm® Robotic HIFU Positioned as Efficient Option for Unilateral Prostate Ablation in Breakthrough Multicenter Study Published in Major Medical Journal
LYON, France , Oct. 11, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the results of a multicentric study using Ablatherm Robotic HIFU which demonstrates promising oncologic outcomes with low side effects.
View HTML
Toggle Summary EDAP Installs Ablatherm Robotic® HIFU at Leading Academic Medical Center
LYON, France , Sept. 12, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the signature of a contract for the installation of Ablatherm Robotic HIFU at the renowned Duke University Hospital located in Durham, North Carolina .
View HTML
Toggle Summary EDAP TMS to Present at the 18th Annual Rodman and Renshaw Global Investment Conference
LYON, France , Sept. 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA  (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer of EDAP TMS , is scheduled to present at the 18 th Annual Rodman & Renshaw Global Investment Conference being
View HTML
Toggle Summary EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016
Total EDAP revenue up 20.4% year-over-year in the first six months of 2016 Continued growth in HIFU system sales and treatment-driven revenue with strong margins Focal One® 510k under FDA review Solid cash position at €21.9 million as of June 30, 2016 LYON, France , Aug.
View HTML
Toggle Summary EDAP's Ablatherm® Robotic HIFU Treats First Patient at Henry Ford Hospital in Detroit
LYON, France , Aug. 22, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Henry Ford Hospital in Detroit, Michigan , using the Company's FDA-cleared Ablatherm Robotic HIFU.
View HTML
Toggle Summary EDAP to Report Second Quarter 2016 Financial Results on August 25, 2016
Conference Call and Webcast Scheduled for 8:30 a.m. ET
View HTML
Toggle Summary EDAP Announces First HIFU Treatments Performed in New England
Ablatherm Robotic HIFU Deployed by HIFU USA; Initial Treatments Performed in New York by Dr. Ron Israeli and in New England by Drs. Clifford Gluck and James Lin
View HTML